Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis

被引:10
|
作者
Kolb, TM
Duan, L
Davis, MA
机构
[1] Lilly Res Labs, Toxicol & Drug Disposit, Greenfield, IN 46140 USA
[2] Univ Maryland, Sch Med, Toxicol Program, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
tumorigenesis; Tsc2; apoptosis; okadaic acid;
D O I
10.1093/toxsci/kfi310
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Although the precise role for the tuberous sclerosis complex-2 tumor suppressor gene (Tsc2) in tumor suppression is not clear, many studies have implicated Tsc2 in the regulation of cell differentiation, cell cycle control, GTPase activity, transcription, polycystin-1 localization, and translation initiation. We propose that Tsc2 also increases susceptibility to apoptosis, and that this functional role may contribute to the tumor suppressor activity of Tsc2. We previously characterized the apoptotic response of a Tsc2-null renal tumor cell line (ERC-18) to the tumor promoter okadaic acid (OKA). In the present study, we expressed Tsc2 in ERC-18 cells and compared the effect of Tsc2 expression on apoptotic induction. Tsc2 expression increased the susceptibility of ERC-18 cells to apoptosis induced by OKA and the phosphatidylinositol-3' kinase inhibitor, LY294002. In addition, Tsc2 expression abrogated OKA-induced cell detachment of ERC-18 cells. These results indicate that the OKA-induced, caspase-independent detachment previously observed in ERC-18 cells is Tsc2-dependent, and may support an additional role for the Tsc2 in regulating cell adhesion.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 50 条
  • [41] Loss of heterozygosity of TSC2 and TSC1 gene in perivascular epithelioid cell tumor (PEComa)
    Pan, CC
    Chung, MY
    MODERN PATHOLOGY, 2006, 19 : 153A - 154A
  • [42] Genetic validation of a TSC2 immunohistochemistry assay in TSC/ mTOR-pathway altered renal tumors
    Akbari, Amir
    Villanueva, Clarence Rachel
    Hes, Ondrej
    Williamson, Sean R.
    Kandukuri, Shivani
    Sharma, Shivani
    Aditi, Aggarwal
    Pivovarcikova, Kristyna
    Argani, Pedram
    Mohanty, Sambit K.
    Asrani, Kaushal
    Lotan, Tamara L.
    HUMAN PATHOLOGY, 2024, 154
  • [43] Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function
    Hunter, DS
    Klotzbücher, M
    Kugoh, H
    Cai, SL
    Mullen, JP
    Manfioletti, G
    Fuhrman, U
    Walker, CL
    CANCER RESEARCH, 2002, 62 (13) : 3766 - 3772
  • [44] Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia
    Xu, Zhifang
    Wang, Min
    Wang, Lin
    Wang, Yang
    Zhao, Xin
    Rao, Qing
    Wang, Jianxiang
    LEUKEMIA RESEARCH, 2009, 33 (07) : 891 - 897
  • [45] Transcriptomic Differences Associated With Tsc2 Gene Expression Loss In Lymphangioleiomyomatosis
    Himes, B. E.
    Shumyatcher, M.
    Atochina-Vasserman, E. N.
    Gow, A. J.
    Guo, C. -J.
    Krymskaya, V. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [46] TSC2 Deficiency Increases PTEN via H1F1α
    Mahimainathan, Lenin
    Ghosh-Choudhury, Nandini
    Venkatesan, Balachandar
    Das, Falguni
    Mandal, Chandi C.
    Dey, Nirmalya
    Habib, Samy L.
    Kasinath, Balakuntalam S.
    Abboud, Hanna E.
    Choudhury, Goutam Ghosh
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (41) : 27790 - 27798
  • [47] The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses
    Rosner, M
    Freilinger, A
    Lubec, G
    Hengstschläger, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (05) : 1411 - 1424
  • [48] Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus
    Wang, Tao
    Xie, Shundiang
    Luo, Rongtuan
    Shi, Lianguo
    Bai, Peide
    Wang, Xuegang
    Wan, Rui
    Deng, Jiang
    Wu, Zhun
    Li, Wei
    Xiao, Wen
    Wang, Yongfeng
    Chen, Bin
    Zhang, Kaiyan
    Xing, Jinchun
    CANCER BIOLOGY & THERAPY, 2020, 21 (01) : 4 - 11
  • [49] Malignancy of renal angiomyolipoma from tuberous sclerosis complex with TSC2 mutation
    HuangYu-Jing
    JiangZong-Pei
    ChenYu-Ping
    WuJin-Quan
    HuangJia-Li
    ChenYan-Qiang
    LiangMeng-Jun
    中华医学杂志英文版, 2019, 132 (01) : 103 - 105
  • [50] PANCREATIC NEUROENDOCRINE TUMOR IN A CHILD WITH A TUBEROUS SCLEROSIS COMPLEX 2 (TSC2) MUTATION
    Bombardieri, Roberta
    Moavero, Romina
    Roberto, Denis
    Cerminara, Caterina
    Curatolo, Paolo
    ENDOCRINE PRACTICE, 2013, 19 (05) : E124 - E128